Myrbetriq (mirabegron)

**Product type:** Human Prescription Drug

**Active ingredient:** MIRABEGRON

**Strength:** 8 mg/mL

**Dosage form:** Granule, For Suspension, Extended Release

**Route:** Oral

**Labeler:** Astellas Pharma US, Inc.

**Marketing category:** NDA (NDA213801)

**Pharmacologic class:** Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]